AFS
MRNA icon

Annapolis Financial Services’s Moderna MRNA Stock Holding History

Annapolis Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.61K Hold
39
– – ﹤0.01% 345
2024
Q2 		$4.63K Hold
39
– – ﹤0.01% 313
2024
Q1 		$4.16K Hold
39
– – ﹤0.01% 314
2023
Q4 		$3.88K Hold
39
– – ﹤0.01% 406
2023
Q3 		$4.03K Hold
39
– – ﹤0.01% 399
2023
Q2 		$4.74K Hold
39
– – ﹤0.01% 397
2023
Q1 		$5.99K Hold
39
– – ﹤0.01% 355
2022
Q4 		$7K Sell
39
-8
-17% -$1.31K ﹤0.01% 335
2022
Q3 		$6K Hold
47
– – ﹤0.01% 380
2022
Q2 		$7K Hold
47
– – ﹤0.01% 311
2022
Q1 		$8K Buy
47
+39
+488% +$6.57K ﹤0.01% 314
2021
Q4 		$2K Hold
8
– – ﹤0.01% 416
2021
Q3 		$3K Hold
8
– – ﹤0.01% 376
2021
Q2 		$2K Sell
8
-16
-67% -$2.86K ﹤0.01% 378
2021
Q1 		$3K Buy
+24
New +$3.48K ﹤0.01% 342

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Annapolis Financial Services's MRNA Position: Q3 2024 in Review

Annapolis Financial Services held its Moderna (MRNA) position steady in Q3 2024 at 39 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #345.

Annapolis Financial Services first reported a position in MRNA in Q1 2021 and has held it in 15 quarters since. The position peaked at $8K in Q1 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Annapolis Financial Services held 39 shares of Moderna worth $2.61K as of Q3 2024.
  • Annapolis Financial Services left its Moderna share count unchanged in Q3 2024.
  • Moderna made up ﹤0.01% of Annapolis Financial Services's portfolio in Q3 2024, its #345 holding.
  • Annapolis Financial Services first reported a position in Moderna in Q1 2021 and has held it in 15 quarters since.
  • Annapolis Financial Services's Moderna position peaked at $8K in Q1 2022.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Annapolis Financial Services's 13F filing for Q3 2024, filed 16 Oct 2024.